Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (1y) (2022 - 2026)
Bluejay Diagnostics (BJDX) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 125.00 |
| 10 | Bluejay Diagnostics | 1.02 Mn | 1.02 Mn | - | 94.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.00 |
| Dec 31, 2025 | -3,523.00 |
| Sep 30, 2025 | -6,131.00 |
| Jun 30, 2025 | 1,312.00 |
| Mar 31, 2025 | 14,936.00 |
| Dec 31, 2024 | 10,835.00 |
| Sep 30, 2024 | 9,279.00 |
| Jun 30, 2024 | -1,498.00 |
| Mar 31, 2024 | -19,985.00 |
| Dec 31, 2023 | -14,361.00 |
| Sep 30, 2023 | -13,297.00 |
| Jun 30, 2023 | -10,288.00 |
| Mar 31, 2023 | -6,574.00 |
| Dec 31, 2022 | -4,418.00 |